Scarica l'app Stockscreener
408.83
0.37%
-1.7799
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HCA Giù?
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$410.61
Aprire:
$408.62
Volume 24 ore:
201.98K
Relative Volume:
0.14
Capitalizzazione di mercato:
$90.70B
Reddito:
$76.39B
Utile/perdita netta:
$7.81B
Rapporto P/E:
14.06
EPS:
29.0772
Flusso di cassa netto:
$7.93B
1 W Prestazione:
-0.34%
1M Prestazione:
+9.12%
6M Prestazione:
-13.34%
1 anno Prestazione:
+8.10%
Intervallo 1D:
$405.99
$412.46
Intervallo di 1 settimana:
$405.99
$429.54
Portata 52W:
$330.00
$556.52
Hca Healthcare Inc Stock (HCA) Company Profile
Nome
Hca Healthcare Inc
Settore
Industria
Telefono
(615) 344-9551
Indirizzo
ONE PARK PLZ, NASHVILLE, TN
Compare HCA vs THC, DVA, FMS, EHC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HCA
Hca Healthcare Inc
|
408.85 | 91.09B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
208.03 | 17.77B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
230.49 | 14.81B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
23.95 | 12.86B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
109.19 | 10.94B | 6.07B | 793.80M | 464.40M | 5.9914 |
Hca Healthcare Inc Stock (HCA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-15 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2025-10-14 | Ripresa | Goldman | Buy |
| 2025-07-28 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2025-07-16 | Downgrade | BofA Securities | Buy → Neutral |
| 2025-05-29 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2025-04-15 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-12-17 | Ripresa | JP Morgan | Neutral |
| 2024-11-25 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2024-11-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2024-10-11 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2024-09-03 | Iniziato | Morgan Stanley | Equal-Weight |
| 2024-05-30 | Iniziato | Robert W. Baird | Outperform |
| 2024-03-06 | Iniziato | Barclays | Overweight |
| 2024-01-04 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2023-12-11 | Downgrade | Goldman | Buy → Neutral |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-04-19 | Ripresa | JP Morgan | Neutral |
| 2022-07-06 | Downgrade | BMO Capital Markets | Market Perform → Underperform |
| 2022-06-17 | Iniziato | Loop Capital | Buy |
| 2022-05-27 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2022-03-29 | Iniziato | Wells Fargo | Equal Weight |
| 2022-01-10 | Ripresa | Citigroup | Buy |
| 2021-12-21 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-09-27 | Iniziato | SVB Leerink | Outperform |
| 2021-09-24 | Iniziato | UBS | Buy |
| 2021-09-10 | Iniziato | Cowen | Outperform |
| 2021-08-12 | Downgrade | Barclays | Overweight → Equal Weight |
| 2021-07-09 | Iniziato | Seaport Global Securities | Buy |
| 2021-05-13 | Ripresa | Citigroup | Neutral |
| 2021-04-26 | Downgrade | Citigroup | Buy → Neutral |
| 2020-12-15 | Iniziato | Goldman | Buy |
| 2020-12-14 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-09-21 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-07-13 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2019-09-06 | Aggiornamento | BofA/Merrill | Underperform → Neutral |
| 2019-07-10 | Aggiornamento | Goldman | Neutral → Buy |
| 2019-04-23 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2019-01-14 | Iniziato | Stephens | Overweight |
| 2019-01-03 | Iniziato | Deutsche Bank | Buy |
| 2018-11-16 | Iniziato | UBS | Buy |
| 2018-03-23 | Ripresa | Mizuho | Buy |
| 2018-01-03 | Iniziato | Goldman | Neutral |
| 2018-01-03 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2017-12-20 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2017-12-12 | Aggiornamento | Citigroup | Neutral → Buy |
| 2017-11-30 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2017-11-06 | Reiterato | Citigroup | Neutral |
| 2017-11-01 | Reiterato | Mizuho | Buy |
| 2017-07-26 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2017-06-28 | Iniziato | Argus | Buy |
Mostra tutto
Hca Healthcare Inc Borsa (HCA) Ultime notizie
HCA Healthcare, Inc. (NYSE:HCA) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
The Premium On HCA Healthcare Keeps Growing. So Does The Case For Universal Health - Trefis
HCA Healthcare (HCA) Could Be 35% Undervalued Following Downgrades And Index Exits - Yahoo Finance
HCA Healthcare Stock And 2 More Names Facing The Next US Immigration Test - simplywall.st
HCA Healthcare (HCA) Publishes Gene Editing Research For Children With Severe Blood Disorders - Yahoo Finance
HCA Healthcare (NYSE:HCA) Expansion Draws Healthcare Market Attention - Kalkine Media
HCA Healthcare Inc. stock outperforms competitors despite losses on the day - MarketWatch
HCA Healthcare Shares Fall After Barclays Downgrade - marketscreener.com
Is the Options Market Predicting a Spike in HCA Healthcare Stock? - Zacks Investment Research
BofA Securities Adjusts HCA Healthcare Price Target to $435 From $415 - Moomoo
HCA Healthcare (HCA): Buy, Sell, or Hold Post Q1 Earnings? - Yahoo Finance
This HCA Healthcare Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Benzinga
Barclays Downgrades HCA Healthcare to Equal Weight From Overweight, Adjusts PT to $427 From $496 - marketscreener.com
Steve Young named chief executive officer of HCA Florida Brandon Hospital - Florida Hospital News and Healthcare Report
HCA Florida Northside Hospital welcomes Brent Burish as chief executive officer - Florida Hospital News and Healthcare Report
Barclays downgrades HCA Healthcare stock rating on volume uncertainty - Investing.com
BofA Securities Upgrades HCA Healthcare(HCA.US) to Buy Rating, Raises Target Price to $435 - Moomoo
Swedbank AB Sells 5,716 Shares of HCA Healthcare, Inc. $HCA - MarketBeat
HCA Healthcare's Fall Shouldn't Be Construed As Failing Health - Seeking Alpha
Is HCA (HCA) Using Index Removal To Quietly Redefine Its Growth and Capital Allocation Playbook? - simplywall.st
CapEx per share of HCA Healthcare Inc – LS:A1JFMW - TradingView
Understanding the Setup: (HCA) and Scalable Risk - Stock Traders Daily
HCA’s North Florida Hospital to end professional chaplain services - Mainstreet Daily News Gainesville
HCA Healthcare Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Can HCA's Capacity Expansion Strategy Fuel Its Long-Term Growth? - Yahoo Finance
HCA Maintained by Cantor Fitzgerald -- Price Target Lowered to $525 - GuruFocus
Ascension outbids HCA, Optum for Williamson Health - Modern Healthcare
Cantor Fitzgerald lowers HCA Healthcare price target to $528 on setup - Investing.com
HCA Healthcare explores long-term growth. US hospital operator focuses on operations and patient vol - AD HOC NEWS
How HCA Healthcare’s (HCA) Advanced Therapy Research Highlights Its High-Acuity Care Capabilities - Yahoo Finance
HCA Healthcare Inc. stock outperforms competitors on strong trading day - MarketWatch
HCA West Florida names new CEOs for Northside, Brandon hospitals - The Business Journals
If EPS Growth Is Important To You, HCA Healthcare (NYSE:HCA) Presents An Opportunity - Moomoo
HCA Healthcare, Inc. (HCA) Stock Analysis: A Robust 21.87% Upside Potential Awaits Investors - DirectorsTalk Interviews
HCA Healthcare Inc Actuals & Estimates (NYSE:HCA) - TradingView
Fideuram Intesa Sanpaolo Private Banking S.P.A. Trims Stock Position in HCA Healthcare, Inc. $HCA - MarketBeat
Elevation Point Wealth Partners LLC Has $10.03 Million Stock Position in HCA Healthcare, Inc. $HCA - MarketBeat
A Look at HCA Healthcare Inc (HCA) After 4.4% Gain -- GF Value $452.20 vs Price $410.50 - GuruFocus
HCA Healthcare Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
HCA Healthcare Jumps 5.2% Amid Sector-Wide Rally - AlphaStreet
HCA Healthcare Foundation awards grants to 89 Middle Tennessee nonprofits, advancing community health - HCA Healthcare Today
HCA Healthcare gains as investors weigh improving physician trends and a possible rebound after prior guidance-driven weakness - Quiver Quantitative
HCAHCA Healthcare Inc Options - Finviz
Cantor Fitzgerald reiterates HCA Healthcare stock rating on physician staffing - Investing.com
HCA Healthcare Earnings Preview: What to Expect - Barchart.com
Can HCA's Gene Therapy Milestone Drive Long-Term Growth? - Yahoo Finance
HCA Healthcare focuses on hospital operations as investors watch US care demand - AD HOC NEWS
HCA Healthcare (HCA) Reports Promising Gene-Editing Therapy Study Results - Insider Monkey
Cantor Fitzgerald reiterates HCA Healthcare stock rating at Overweight - Investing.com
Cantor Fitzgerald reiterates HCA Healthcare stock rating at Overweight By Investing.com - Investing.com Canada
HCA Healthcare (HCA): 12 Best Value Stocks to Buy Right Now - Insider Monkey
Hca Healthcare Inc Azioni (HCA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.08%
0.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):